Improved tumour targeting with recombinant antibody–macrocycle conjugates

Abstract

Linkage of a macrocyclic complexing agent to a spaced tri-maleimide allows formation of a recombinant trivalent antibody by reaction with a Δ-Cys Fab fragment of an engineered human antibody.